Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Tsuda

Showing results (391-400 of 478) with videos related to

Pageof 48
Sort By:
Human Pathology|August 7, 2013
Prognostic implications of histologic grade and intensity of Bcl-2 expression in follicular lymphomas undergoing rituximab-containing therapyAkiko Miyagi Maeshima, Hirokazu Taniguchi, Junko Nomoto, et al.
Esophagus : Official Journal of the Japan Esophageal Society|November 29, 2025
AI-driven spatial mapping of myxoid stroma and tumor-infiltrating lymphocytes in esophageal squamous cell carcinomaKeita Kouzu, Hironori Tsujimoto, Ines P Nearchou, et al.
Cancer Science|March 21, 2022
Overexpression of Tetraspanin31 contributes to malignant potential and poor outcomes in gastric cancerYusuke Takashima, Shuhei Komatsu, Takuma Ohashi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 TrialToru Watanabe, Muneaki Sano, Shigemitsu Takashima, et al.
Oncology|March 21, 2019
Pretreatment Neutrophil-to-Lymphocyte Ratio Was a Predictor of Lymph Node Metastasis in Endometrial Cancer PatientsTadashi Aoyama, Masashi Takano, Morikazu Miyamoto, et al.
Clinical Breast Cancer|December 14, 2011
Randomized phase II study of primary systemic chemotherapy and trastuzumab for operable HER2 positive breast cancerSeigo Nakamura, Masashi Ando, Norikazu Masuda, et al.
Cancer Letters|February 19, 2008
Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinomaShin Nishio, Kimio Ushijima, Naotake Tsuda, et al.
Molecular and Clinical Oncology|July 19, 2021
Psoas muscle index at the fifth lumbar vertebra as a predictor of survival in epithelial ovarian cancersTomoyuki Yoshikawa, Morikazu Miyamoto, Tadashi Aoyama, et al.
Pathology International|April 18, 2015
The expression and clinical significance of ribophorin II (RPN2) in human breast cancerMakiko Ono, Hitoshi Tsuda, Takayuki Kobayashi, et al.
Anticancer Research|January 29, 2018
Low Expression of CD44 Is an Independent Factor of Poor Prognosis in Ovarian Mucinous CarcinomaHiroko Matuura, Morikazu Miyamoto, Masashi Takano, et al.
Pageof 48

Showing results (391-400 of 478) with videos related to

Sort By:
Pageof 48
Human Pathology|August 7, 2013
Prognostic implications of histologic grade and intensity of Bcl-2 expression in follicular lymphomas undergoing rituximab-containing therapyAkiko Miyagi Maeshima, Hirokazu Taniguchi, Junko Nomoto, et al.
Esophagus : Official Journal of the Japan Esophageal Society|November 29, 2025
AI-driven spatial mapping of myxoid stroma and tumor-infiltrating lymphocytes in esophageal squamous cell carcinomaKeita Kouzu, Hironori Tsujimoto, Ines P Nearchou, et al.
Cancer Science|March 21, 2022
Overexpression of Tetraspanin31 contributes to malignant potential and poor outcomes in gastric cancerYusuke Takashima, Shuhei Komatsu, Takuma Ohashi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 TrialToru Watanabe, Muneaki Sano, Shigemitsu Takashima, et al.
Oncology|March 21, 2019
Pretreatment Neutrophil-to-Lymphocyte Ratio Was a Predictor of Lymph Node Metastasis in Endometrial Cancer PatientsTadashi Aoyama, Masashi Takano, Morikazu Miyamoto, et al.
Clinical Breast Cancer|December 14, 2011
Randomized phase II study of primary systemic chemotherapy and trastuzumab for operable HER2 positive breast cancerSeigo Nakamura, Masashi Ando, Norikazu Masuda, et al.
Cancer Letters|February 19, 2008
Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinomaShin Nishio, Kimio Ushijima, Naotake Tsuda, et al.
Molecular and Clinical Oncology|July 19, 2021
Psoas muscle index at the fifth lumbar vertebra as a predictor of survival in epithelial ovarian cancersTomoyuki Yoshikawa, Morikazu Miyamoto, Tadashi Aoyama, et al.
Pathology International|April 18, 2015
The expression and clinical significance of ribophorin II (RPN2) in human breast cancerMakiko Ono, Hitoshi Tsuda, Takayuki Kobayashi, et al.
Anticancer Research|January 29, 2018
Low Expression of CD44 Is an Independent Factor of Poor Prognosis in Ovarian Mucinous CarcinomaHiroko Matuura, Morikazu Miyamoto, Masashi Takano, et al.
Pageof 48